alexa Why Do We Need Pharmacovigilance In India?
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Ratinder Jhaj
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.012
Abstract
According to various estimates, Adverse Drug Reactions occur in 10-20% of hospital inpatients, account for 2-6 % of all hospital admissions, and are among top 10 causes of death in inpatients. Overall incidence of serious ADRs is about 6. 7 % and for fatal ADRs it is 0.32%. 15-20% of hospital budget may be spent dealing with drug complications. 30% to 60% of ADRs are preventable. More than 121 medicines were withdrawn for safety reasons in last 40 years- 33% within 2 years of marketing, 50% within 5 years. Tests in animals may not predict human safety. In clinical trials, patients are few, selection is narrow, indications are limited and time is brief. Therefore, information about rare but serious adverse effects, chronic toxicity, use in special groups and drug interactions often are incomplete or not available. Pharmacovigilance helps by early detection of unknown ADRs, detection of increase in frequency of ADRs, identification of risk factors and possible mechanisms underlying ADRs, estimation of benefit/risk, dissemination of information and taking necessary actions e.g., ban/withdraw the drug, insert suitable warnings, restrict use, modify OTC/prescription only status. Why do we need Pharmacovigilance in India? There are differences in ADRs between countries because of differences in drug availability, use, genetics, diet, pharmaceutical quality, use of alternative medicines, OTC availability of ?prescription only? drugs, multiple systems of healthcare. Moreover, Indian Pharmaceutical industry is worth more than Rs. 90,000 crores & growing at 12-14% per annum. India is the global clinical trial hub and there is almost simultaneous global introduction of new medicines.
Biography
Ratinder Jhaj has completed her MD (Pharmacology) and DM (Clinical Pharmacology) from PGIMER, Chandigarh. She is currently working as an Associate Professor in the department of Pharmacology All India Institutes of Medical Sciences, Bhopal. She is also the Coordinator for the newly designated ADR Monitoring Centre under Pharmacovigilance Program of India at All India Institutes of Medical Sciences, Bhopal. Her research interests lies mainly in the field of Pharmacoepidemiology including Pharmaco-economics, Pharmacovigilance, Rational Drug Use and Prescription Audits. She has 18 national and international publications and has been a resource person for many workshops on Clinical Pharmacology, Research Methodology, Essential Medicines and Pharmacoeconomics.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords